Hyperbaric Oxygen Therapy for Osteoradionecrosis of the Jaw
Osteoradionecrosis of the jaw is a complication that can develop following radiotherapy to the head or neck. It involves damage to bone tissue and may affect oral health, comfort and everyday activities.
Hyperbaric Oxygen Therapy (HBOT) has been investigated in connection with radiation-related tissue injury, including osteoradionecrosis. However, its effectiveness for preventing or managing osteoradionecrosis of the jaw remains uncertain, and recent clinical guidance identifies significant limitations in the evidence.
This article examines the condition, why hyperbaric oxygen has been studied and the importance of specialist medical and dental care.
What Is Osteoradionecrosis of the Jaw?
Osteoradionecrosis (ORN) occurs when bone previously exposed to radiotherapy becomes damaged and may struggle to maintain normal tissue integrity.
The condition can affect the upper or lower jaw, although the mandible is particularly vulnerable.
Radiotherapy is an important treatment for many cancers, but radiation exposure can sometimes affect healthy tissues in the surrounding area.
Over time, changes in blood vessels, tissue structure and natural repair processes may contribute to complications involving the jawbone.
Possible symptoms include:
- Persistent discomfort or pain around the jaw.
- Exposed bone within the mouth.
- Difficulty chewing or opening the mouth.
- Swelling or inflammation.
- Delayed healing following dental procedures.
- Recurrent infections or changes in the surrounding soft tissues.
Symptoms can vary considerably. People who have previously received head or neck radiotherapy should report concerning oral symptoms to their dental or oncology team.
Why Has HBOT Been Investigated for Radiation-Related Jaw Injury?
Hyperbaric oxygen therapy has a history of investigation in certain forms of delayed radiation injury.
Researchers have explored whether increased oxygen availability within a pressurised clinical environment might influence the tissue environment in areas previously affected by radiotherapy.
Oxygen Availability in Irradiated Tissue
Radiotherapy can produce long-term changes in blood vessels and surrounding tissue.
Clinical HBOT increases oxygen availability within blood plasma, prompting research into how tissues affected by radiation exposure might respond.
Tissue Repair Processes
Some studies have examined whether hyperbaric oxygen exposure may influence biological processes associated with tissue maintenance and repair.
Use Alongside Specialist Care
HBOT has also been investigated in combination with dental surgery and other approaches to the management of osteoradionecrosis.
These proposed mechanisms do not establish that HBOT can heal damaged jawbone or prevent complications.
What Does the Clinical Evidence Say?
Research into hyperbaric oxygen for osteoradionecrosis has produced mixed findings.
Some earlier studies explored whether HBOT might influence tissue outcomes in selected patients. However, differences in research methods, sample sizes and clinical management have made firm conclusions difficult.
Importantly, a 2024 joint guideline from the International Society of Oral Oncology, the Multinational Association of Supportive Care in Cancer and the American Society of Clinical Oncology concluded that there was limited evidence supporting the use of HBOT to prevent or manage osteoradionecrosis of the jaw.
The guideline did not support routine preventive use before dental extractions in patients who had previously undergone head and neck radiotherapy.
Clinical decisions should therefore be based on current specialist guidance and individual medical circumstances, rather than assumptions about the benefits of hyperbaric oxygen.
How Is Osteoradionecrosis Usually Managed?
Management depends on the extent of the condition, the person’s symptoms and their previous cancer treatment.
A specialist team may consider:
- Regular dental and oral health assessments.
- Careful management of infections.
- Oral hygiene support and appropriate medication.
- Monitoring changes in the affected jawbone.
- Surgical treatment in selected cases.
- Coordinated care between oncology, dentistry and maxillofacial specialists.
Appropriate professional care remains central to managing osteoradionecrosis.
Understanding Clinical HBOT and Hyperbaric Chamber Equipment
Clinical research into osteoradionecrosis generally concerns specialist hyperbaric treatment delivered under medical supervision.
These settings may involve specific oxygen concentrations, pressure levels, treatment protocols and monitoring arrangements.
The equipment used in clinical research may differ substantially from hyperbaric chambers supplied for home or general-wellbeing purposes.
It should not be assumed that an Origin Oxygen chamber is suitable for treating radiation-related jaw injury or that research findings apply to a particular product.
Frequently Asked Questions
HBOT has been researched as a possible intervention, but available evidence is limited. Current specialist guidance does not support assuming that HBOT will improve osteoradionecrosis outcomes.
Researchers have investigated possible effects on radiation-damaged tissues, but there is insufficient evidence to guarantee improvement or establish HBOT as a routine treatment.
Routine preventive HBOT before dental extractions is not recommended in the 2024 international clinical guideline. Individual treatment decisions should be made by the relevant specialist team.
Osteoradionecrosis is a specific form of radiation-related bone injury. Other delayed radiation injuries may affect different tissues and require different assessment and management.
No such therapeutic use should be assumed. A home or general-wellbeing chamber is not automatically equivalent to specialist clinical HBOT equipment.
Learn More About Hyperbaric Chamber Technology
Origin Oxygen provides information and equipment options for customers researching hyperbaric chambers.
Our team can explain the technical differences between chamber models, including pressure capabilities, configuration, installation and documented intended use.
The management of osteoradionecrosis must remain with suitably qualified dental, oncology and maxillofacial professionals.
For further educational information, explore our guide to delayed radiation injury or contact Origin Oxygen for chamber specifications.
Medical disclaimer: This article is intended for general education. It does not establish that any Origin Oxygen product can prevent, manage, treat or cure osteoradionecrosis or radiation-related complications.
Clinical references
2024 ISOO–MASCC–ASCO guideline — https://pubmed.ncbi.nlm.nih.gov/38691821/